+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Companion Animal Veterinary Vaccines Global Market Report 2021: COVID-19 Growth and Change to 2030

  • ID: 5321415
  • Report
  • May 2021
  • Region: Global
  • The Business Research Company

FEATURED COMPANIES

  • Bayer Healthcare
  • Boehringer Ingelheim
  • Heska Co.
  • ImmuCell Corporation
  • Merck Animal Health
  • NEOGEN CORPORATION
  • MORE

Companion Animal Veterinary Vaccines Global Market Report 2021: COVID-19 Growth and Change to 2030 provides the strategists, marketers and senior management with the critical information they need to assess the global companion animal veterinary vaccines market.

This report focuses on the companion animal veterinary vaccines market which is experiencing strong growth. The report gives a guide to the companion animal veterinary vaccines market which will be shaping and changing our lives over the next ten years and beyond, including the market's response to the challenge of the global pandemic.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 12+ geographies.
  • Understand how the market is being affected by the coronavirus and how it is likely to emerge and grow as the impact of the virus abates.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market research findings.
  • Benchmark performance against key competitors.
  • Utilize the relationships between key data sets for superior strategizing.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 3-5 working days of order.

Description:

Where is the largest and fastest growing market for the companion animal veterinary vaccines? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The Companion Animal Veterinary Vaccines market global report answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography. It places the market within the context of the wider companion animal veterinary vaccines market, and compares it with other markets.

The market characteristics section of the report defines and explains the market.

  • The market size section gives the market size ($b) covering both the historic growth of the market, the influence of the COVID-19 virus and forecasting its growth.
  • Market segmentations break down market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • Competitive landscape gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
  • The companion animal veterinary vaccines market section of the report gives context. It compares the companion animal veterinary vaccines market with other segments of the companion animal veterinary vaccines market by size and growth, historic and forecast. It analyses GDP proportion, expenditure per capita, companion animal veterinary vaccines indicators comparison.

Scope

Markets Covered:

1) By Product: Inactivated; Live Attenuated; Recombinant; Others 2) By Route Of Administration: Oral; Parenteral; Others 3) By Distribution Channel: Veterinary Hospitals; Veterinary Clinics; Pharmacies & Drug Stores; Others

Companies Mentioned: Boehringer Ingelheim; Eli Lilly and Company (Elcano); Heska Co.; Merck Animal Health; Virbac

Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA

Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa

Time series: Five years historic and ten years forecast.

Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,

Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.

Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.

Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • Bayer Healthcare
  • Boehringer Ingelheim
  • Heska Co.
  • ImmuCell Corporation
  • Merck Animal Health
  • NEOGEN CORPORATION
  • MORE
1. Executive Summary

2. Companion Animal Veterinary Vaccines Market Characteristics

3. Companion Animal Veterinary Vaccines Market Trends and Strategies

4. Impact of COVID-19 on Companion Animal Veterinary Vaccines

5. Companion Animal Veterinary Vaccines Market Size and Growth
5.1. Global Companion Animal Veterinary Vaccines Historic Market, 2015-2020, $ Billion
5.1.1. Drivers of the Market
5.1.2. Restraints on The Market
5.2. Global Companion Animal Veterinary Vaccines Forecast Market, 2020-2025F, 2030F, $ Billion
5.2.1. Drivers of the Market
5.2.2. Restraints on the Market

6. Companion Animal Veterinary Vaccines Market Segmentation
6.1. Global Companion Animal Veterinary Vaccines Market, Segmentation By Product, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Inactivated
  • Live Attenuated
  • Recombinant
  • Others
6.2. Global Companion Animal Veterinary Vaccines Market, Segmentation By Route of Administration, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Oral
  • Parenteral
  • Others
6.3. Global Companion Animal Veterinary Vaccines Market, Segmentation By Distribution Channel, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Veterinary Hospitals
  • Veterinary Clinics
  • Pharmacies & Drug Stores
  • Others
7. Companion Animal Veterinary Vaccines Market Regional and Country Analysis
7.1. Global Companion Animal Veterinary Vaccines Market, Split By Region, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
7.2. Global Companion Animal Veterinary Vaccines Market, Split By Country, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

8. Asia-Pacific Companion Animal Veterinary Vaccines Market
8.1. Asia-Pacific Companion Animal Veterinary Vaccines Market Overview
  • Region Information, Impact of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Companion Animal Veterinary Vaccines Market, Segmentation By Product, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
8.3. Asia-Pacific Companion Animal Veterinary Vaccines Market, Segmentation By Route of Administration:, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

9. China Companion Animal Veterinary Vaccines Market
9.1. China Companion Animal Veterinary Vaccines Market Overview
9.2. China Companion Animal Veterinary Vaccines Market, Segmentation By Product, Historic and Forecast, 2015-2020, 2020-2025F, 2030F,$ Billion
9.3. China Companion Animal Veterinary Vaccines Market, Segmentation By Route of Administration:, Historic and Forecast, 2015-2020, 2020-2025F, 2030F,$ Billion

10. India Companion Animal Veterinary Vaccines Market
10.1. India Companion Animal Veterinary Vaccines Market, Segmentation By Product, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
10.2. India Companion Animal Veterinary Vaccines Market, Segmentation By Route of Administration:, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

11. Japan Companion Animal Veterinary Vaccines Market
11.1. Japan Companion Animal Veterinary Vaccines Market, Segmentation By Product, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
11.2. Japan Companion Animal Veterinary Vaccines Market, Segmentation By Route of Administration:, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

12. Australia Companion Animal Veterinary Vaccines Market
12.1. Australia Companion Animal Veterinary Vaccines Market, Segmentation By Product, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
12.2. Australia Companion Animal Veterinary Vaccines Market, Segmentation By Route of Administration:, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

13. Indonesia Companion Animal Veterinary Vaccines Market
13.1. Indonesia Companion Animal Veterinary Vaccines Market, Segmentation By Product, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
13.2. Indonesia Companion Animal Veterinary Vaccines Market, Segmentation By Route of Administration:, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

14. South Korea Companion Animal Veterinary Vaccines Market
14.1. South Korea Companion Animal Veterinary Vaccines Market, Segmentation By Product, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
14.2. South Korea Companion Animal Veterinary Vaccines Market, Segmentation By Route of Administration:, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

15. Western Europe Companion Animal Veterinary Vaccines Market
15.1. Western Europe Companion Animal Veterinary Vaccines Market Overview
15.2. Western Europe Companion Animal Veterinary Vaccines Market, Segmentation By Product, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
15.3. Western Europe Companion Animal Veterinary Vaccines Market, Segmentation By Route of Administration:, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

16. UK Companion Animal Veterinary Vaccines Market
16.1. UK Companion Animal Veterinary Vaccines Market, Segmentation By Product, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
16.2. UK Companion Animal Veterinary Vaccines Market, Segmentation By Route of Administration:, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

17. Germany Companion Animal Veterinary Vaccines Market
17.1. Germany Companion Animal Veterinary Vaccines Market, Segmentation By Product, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
17.2. Germany Companion Animal Veterinary Vaccines Market, Segmentation By Route of Administration:, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

18. France Companion Animal Veterinary Vaccines Market
18.4. France Companion Animal Veterinary Vaccines Market, Segmentation By Product, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
18.5. France Companion Animal Veterinary Vaccines Market, Segmentation By Route of Administration:, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

19. Eastern Europe Companion Animal Veterinary Vaccines Market
19.1. Eastern Europe Companion Animal Veterinary Vaccines Market Overview
19.2. Eastern Europe Companion Animal Veterinary Vaccines Market, Segmentation By Product, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
19.3. Eastern Europe Companion Animal Veterinary Vaccines Market, Segmentation By Route of Administration:, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

20. Russia Companion Animal Veterinary Vaccines Market
20.1. Russia Companion Animal Veterinary Vaccines Market, Segmentation By Product, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
20.2. Russia Companion Animal Veterinary Vaccines Market, Segmentation By Route of Administration:, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

21. North America Companion Animal Veterinary Vaccines Market
21.1. North America Companion Animal Veterinary Vaccines Market Overview
21.2. North America Companion Animal Veterinary Vaccines Market, Segmentation By Product, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
21.3. North America Companion Animal Veterinary Vaccines Market, Segmentation By Route of Administration:, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

22. USA Companion Animal Veterinary Vaccines Market
22.1. USA Companion Animal Veterinary Vaccines Market Overview
22.2. USA Companion Animal Veterinary Vaccines Market, Segmentation By Product, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
22.3. USA Companion Animal Veterinary Vaccines Market, Segmentation By Route of Administration:, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

23. South America Companion Animal Veterinary Vaccines Market
23.1. South America Companion Animal Veterinary Vaccines Market Overview
23.2. South America Companion Animal Veterinary Vaccines Market, Segmentation By Product, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
23.3. South America Companion Animal Veterinary Vaccines Market, Segmentation By Route of Administration:, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

24. Brazil Companion Animal Veterinary Vaccines Market
24.1. Brazil Companion Animal Veterinary Vaccines Market, Segmentation By Product, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
24.2. Brazil Companion Animal Veterinary Vaccines Market, Segmentation By Route of Administration:, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

25. Middle East Companion Animal Veterinary Vaccines Market
25.1. Middle East Companion Animal Veterinary Vaccines Market Overview
25.2. Middle East Companion Animal Veterinary Vaccines Market, Segmentation By Product, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
25.3. Middle East Companion Animal Veterinary Vaccines Market, Segmentation By Route of Administration:, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

26. Africa Companion Animal Veterinary Vaccines Market
26.1. Africa Companion Animal Veterinary Vaccines Market Overview
26.2. Africa Companion Animal Veterinary Vaccines Market, Segmentation By Product, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
26.3. Africa Companion Animal Veterinary Vaccines Market, Segmentation By Route of Administration:, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

27. Companion Animal Veterinary Vaccines Market Competitive Landscape and Company Profiles
27.1. Companion Animal Veterinary Vaccines Market Competitive Landscape
27.2. Companion Animal Veterinary Vaccines Market Company Profiles
27.2.1. Boehringer Ingelheim
27.2.1.1. Overview
27.2.1.2. Products and Services
27.2.1.3. Strategy
27.2.1.4. Financial Performance
27.2.2. Eli Lilly and Company (Elcano)
27.2.2.1. Overview
27.2.2.2. Products and Services
27.2.2.3. Strategy
27.2.2.4. Financial Performance
27.2.3. Heska Co.
27.2.3.1. Overview
27.2.3.2. Products and Services
27.2.3.3. Strategy
27.2.3.4. Financial Performance
27.2.4. Merck Animal Health
27.2.4.1. Overview
27.2.4.2. Products and Services
27.2.4.3. Strategy
27.2.4.4. Financial Performance
27.2.5. Virbac
27.2.5.1. Overview
27.2.5.2. Products and Services
27.2.5.3. Strategy
27.2.5.4. Financial Performance

28. Key Mergers and Acquisitions in the Companion Animal Veterinary Vaccines Market

29. Companion Animal Veterinary Vaccines Market Future Outlook and Potential Analysis

30. Appendix
30.1. Abbreviations
30.2. Currencies
30.3. Research Inquiries
30.4. About the Publisher
30.5. Copyright and Disclaimer
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • Bayer Healthcare
  • Boehringer Ingelheim
  • Heska Co.
  • ImmuCell Corporation
  • Merck Animal Health
  • NEOGEN CORPORATION
  • MORE
Major players in the companion animal veterinary vaccines market are Boehringer Ingelheim, Eli Lilly and Company (Elcano), Heska Co., Merck Animal Health, Virbac, Zoetis, and Elanco.

The global companion animal veterinary vaccines market is expected to grow from $2.599 billion in 2020 to $2.755 billion in 2021 at a compound annual growth rate (CAGR) of 6%. The growth is mainly due to the companies resuming their operations and adapting to the new normal while recovering from the COVID-19 impact, which had earlier led to restrictive containment measures involving social distancing, remote working, and the closure of commercial activities that resulted in operational challenges. The market is expected to reach $3.848 billion in 2025 at a CAGR of 9%.

The companion animal veterinary vaccines market consists of sales of companion animal vaccines by entities (organizations, sole traders and partnerships) that manufacture companion animal vaccines. Companion animal vaccines are substances that are used to stimulate the production of antibodies and provide immunity against one or several diseases in pets such as dogs, birds and cats. Only goods and services traded between entities or sold to end consumers are included.

Companies in the companion animal veterinary vaccine industry are increasingly collaborating and partnering with other players to drive product innovations. To succeed in the increasingly competitive veterinary market, companion animal veterinary vaccines companies are entering into new geographies and developing innovative products through sharing skills and expertise with other players. In June 2018, Merck & Co.’s subsidiary MSD Animal Health announced a strategic partnership with Vinovo B.V., a division of Viscon Hatchery Automation, the leading hatchery automation company, to provide a new standard in safe and effective in ovo vaccination to improve bird welfare and reduce vaccine reactions. In June 2017, Zoetis collaborated with a multidisciplinary team of public and private partners spanning animal and human health.

The companion animal veterinary vaccines market covered in this report is segmented by product into inactivated; live attenuated; recombinant; others. It is also segmented by route of administration into oral; parenteral; others and by distribution channel into veterinary hospitals; veterinary clinics; pharmacies & drug stores; others.

In April 2019, Merck Animal Health, a US-based company that is involved in manufacturing, fabricating or processing of drugs for human or veterinary use, acquired Antelliq Corporation for about $2.4 billion. Through this acquisition, Merck Animal Health aims to implement animal health digital tracking, traceability and monitoring technology and complement the existing portfolio of vaccines and pharmaceuticals. Antelliq Corporation is an animal intelligence group that provides devices for animal identification, monitoring and traceability.

Increased pet ownership by Gen X and Gen Y adults contributed to the growth of the companion animal veterinary vaccines market during the historic period. According to the APPA, millennials, or Gen Y represents the largest segment of pet owners for all types of pets. More than 80% of Gen Y and Gen Z own a dog and 50% or less owns a cat as a pet. Multiple pet ownership is also on the rise in some parts of the world. In the USA, nearly 57% of all households owned pets in 2016. According to the 2019-2020 APPA National Pet Owners Survey, 67% of US households own pets, which is equal to 84.9 million homes. Pet owners are well aware of advanced facilities and are willing to spend a large amount of money on the health of their pets. Therefore, the rise in pet ownership aids in the growth of the companion animal veterinary vaccines market.

The high cost of veterinary vaccines is expected to restrain the growth of the market. According to data from Harris Interactive, in 2015, in the USA, households with pets spent about $1,000 in pet care. There are around 70% of households in the USA who own a pet and only 39% have enough in their savings to cover high spending related to pet care. According to a report by PET IQ in 2019, in the USA, nearly 28% of households experienced barriers to veterinary care in the past two years. 80% of pet owners are unable to obtain preventative care due to financial constraints. There are several instances when it happens that the pet owners cannot afford expensive animal treatment and this factor restrained the growth of the companion animal veterinary vaccines market. Usually, the average cost of the rabies vaccine varies typically from about $1,200 to $6,500. Thus, the high costs for companion animal veterinary vaccines will restrain the growth of the market over the forecast period.
Note: Product cover images may vary from those shown

A selection of companies mentioned in this report includes:

  • Boehringer Ingelheim
  • Eli Lilly and Company (Elcano)
  • Heska Co.
  • Merck Animal Health
  • Virbac
  • Zoetis
  • ElancoCeva Sante Animal S.A.
  • Bayer Healthcare
  • NEOGEN CORPORATION
  • ImmuCell Corporation
  • Intervet Inc. (Merck Animal Health)
Note: Product cover images may vary from those shown

Loading
LOADING...

Adroll
adroll